Graypoint LLC
- SEC CIK
- 0001794198
- Latest filing
- Jul 15, 2025
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Graypoint LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2025 holdings
- Shares (Q2 2025)
- 2,839
- Value
- $1.26M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 2,839 | $1.26M | 0.1% | −75−2.6% | Reduced | Holders |
| Q1 2025 | 2,914 | $1.41M | 0.1% | +12+0.4% | Added | Holders |
| Q4 2024 | 2,902 | $1.17M | 0.1% | −104−3.5% | Reduced | Holders |
| Q3 2024 | 3,006 | $1.40M | 0.1% | +101+3.5% | Added | Holders |
| Q2 2024 | 2,905 | $1.36M | 0.1% | +578+24.8% | Added | Holders |
| Q1 2024 | 2,327 | $972.7K | 0.1% | +88+3.9% | Added | Holders |
| Q4 2023 | 2,239 | $911.0K | 0.1% | +189+9.2% | Added | Holders |
| Q3 2023 | 2,050 | $712.9K | 0.1% | +339+19.8% | Added | Holders |
| Q2 2023 | 1,711 | $602.1K | 0.1% | +579+51.1% | Added | Holders |
| Q1 2023 | 1,132 | $356.7K | <0.1% | +312+38.0% | Added | Holders |
| Q4 2022 | 820 | $236.8K | <0.1% | +18+2.2% | Added | Holders |
| Q3 2022 | 802 | $232.0K | <0.1% | +802 | New | Holders |